Attention SLTM Shareholders: The Proposed Buyout of Solta Medical, Inc by Valeant Pharmaceuticals International, Inc is Under Investigation By The Young Law Firm Business Wire PHOENIXVILLE, Pa. -- December 17, 2013 The Young Law Firm, a national shareholder litigation firm, is investigating potential claims concerning the proposed acquisition of Solta Medical, Inc (“Solta Medical” or the “Company”) (Nasdaq: SLTM) by Valeant Pharmaceuticals International, Inc. The investigation concerns whether the proposed buyout price represents fair value for the sale of the Company and whether the interests of the Company’s public shareholders have been adequately protected. Pursuant to the terms of the proposed transaction, shareholders of Solta Medical will receive $2.92 per share in an all cash transaction valued at approximately $250 million. Individual shareholders have rights. The Young Law Firm is seeking to speak with shareholders interested in ensuring that their rights are being protected. If you own shares of the Company and would like to learn more about the buyout of Solta Medical please contact the Firm’s founder, Henry Young, at: Henry Young Esq. The Young Law Firm Toll Free: (888) 452-7252 Email: firstname.lastname@example.org or visit: www.mergersbuyoutsandfraud.com/solta-medical-merger-buyout-shareholder-lawsuit-sltm/ Henry Young Esq. has over 10 years of experience litigating complex shareholder class action lawsuits, including cases resulting in the recovery of millions of dollars for shareholders. The Firm routinely works with and refers cases to other leading law firms around the country to enforce shareholder rights. For more information about the Firm and shareholder cases in general, please visit our website: www.theyounglf.com. This press release may be considered attorney advertising. Past results do not guarantee future performance. Contact: The Young Law Firm Henry Young Esq. Toll Free: (888) 452-7252 email@example.com
Attention SLTM Shareholders: The Proposed Buyout of Solta Medical, Inc by Valeant Pharmaceuticals International, Inc is Under
Press spacebar to pause and continue. Press esc to stop.